HighLife SAS's TMVR System Receives FDA Breakthrough Device Designation
CompanyMedical Device

HighLife SAS’s TMVR System Receives FDA Breakthrough Device Designation

Zhifei Biological Gains Bangladesh Approval for Dysentery Vaccine Trial
CompanyDrug

Zhifei Biological Gains Bangladesh Approval for Dysentery Vaccine Trial

Hengrui Pharmaceuticals' Vunakizumab Approved for Ankylosing Spondylitis
CompanyDrug

Hengrui Pharmaceuticals’ Vunakizumab Approved for Ankylosing Spondylitis

CSPC Pharmaceutical's JMT108 Gains FDA Approval for Advanced Malignant Tumor Trials
CompanyDrug

CSPC Pharmaceutical’s JMT108 Gains FDA Approval for Advanced Malignant Tumor Trials

Amgen's Uplizna Approved by FDA for IgG4-Related Disease
CompanyDrug

Amgen’s Uplizna Approved by FDA for IgG4-Related Disease

J&J's Rybrevant SC Formulation Approved by EC for NSCLC Treatment
CompanyDrug

J&J’s Rybrevant SC Formulation Approved by EC for NSCLC Treatment

TJ Biopharma Partners with Biogen on Felzartamab Phase III Studies in China
CompanyDeals

TJ Biopharma Partners with Biogen on Felzartamab Phase III Studies in China

J&J's Darzalex SC Formulation Approved for Newly Diagnosed Multiple Myeloma
CompanyDrug

J&J’s Darzalex SC Formulation Approved for Newly Diagnosed Multiple Myeloma

Shenzhen Unveils Comprehensive Policy Package to Boost Biopharma Innovation
Policy / Regulatory

Shenzhen Unveils Comprehensive Policy Package to Boost Biopharma Innovation

AIM Vaccine's Serum-Free Rabies Vaccine Accepted for Review by NMPA
CompanyDrug

AIM Vaccine’s Serum-Free Rabies Vaccine Accepted for Review by NMPA

SinoMab BioScience's SM17 Shows Promising Results in Phase Ib Atopic Dermatitis Study
CompanyDrug

SinoMab BioScience’s SM17 Shows Promising Results in Phase Ib Atopic Dermatitis Study

Luye Pharma's Toludesvenlafaxine Approved for Marketing in Macau
CompanyDrug

Luye Pharma’s Toludesvenlafaxine Approved for Marketing in Macau